Literature DB >> 22665526

Novel insights on TLX1 function in T-ALL pave the way towards differentiation therapy.

Kim De Keersmaecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22665526      PMCID： PMC3366640          DOI： 10.3324/haematol.2012.070227

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

Review 1.  Acute promyelocytic leukemia: from treatment to genetics and back.

Authors:  S C Kogan; J M Bishop
Journal:  Oncogene       Date:  1999-09-20       Impact factor: 9.867

2.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

3.  Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.

Authors:  Qian Wang; Huiying Qiu; Hui Jiang; Lili Wu; Shasha Dong; Jinlan Pan; Wenjuan Wang; Nana Ping; Jing Xia; Aining Sun; Depei Wu; Yongquan Xue; Hans G Drexler; Roderick A F Macleod; Suning Chen
Journal:  Haematologica       Date:  2011-08-31       Impact factor: 9.941

4.  Inactivation of LEF1 in T-cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Takaomi Sanda; Wenxue Ma; Jianhua Zhang; Ruta Grebliunaite; Suzanne Dahlberg; Donna Neuberg; Alexei Protopopov; Stuart S Winter; Richard S Larson; Michael J Borowitz; Lewis B Silverman; Lynda Chin; Stephen P Hunger; Catriona Jamieson; Stephen E Sallan; A Thomas Look
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

5.  TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCRα gene expression.

Authors:  Saïda Dadi; Sandrine Le Noir; Dominique Payet-Bornet; Ludovic Lhermitte; Joaquin Zacarias-Cabeza; Julie Bergeron; Patrick Villarèse; Elodie Vachez; Willem A Dik; Corinne Millien; Isabelle Radford; Els Verhoeyen; François-Loïc Cosset; Arnaud Petit; Norbert Ifrah; Hervé Dombret; Olivier Hermine; Salvatore Spicuglia; Anton W Langerak; Elizabeth A Macintyre; Bertrand Nadel; Pierre Ferrier; Vahid Asnafi
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

Review 6.  Molecular pathogenesis of T-cell leukaemia and lymphoma.

Authors:  Iannis Aifantis; Elizabeth Raetz; Silvia Buonamici
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

7.  The TLX1 oncogene drives aneuploidy in T cell transformation.

Authors:  Kim De Keersmaecker; Pedro J Real; Giusy Della Gatta; Teresa Palomero; Maria Luisa Sulis; Valeria Tosello; Pieter Van Vlierberghe; Kelly Barnes; Mireia Castillo; Xavier Sole; Michael Hadler; Jack Lenz; Peter D Aplan; Michelle Kelliher; Barbara L Kee; Pier Paolo Pandolfi; Dietmar Kappes; Fotini Gounari; Howard Petrie; Joni Van der Meulen; Frank Speleman; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Jean Soulier; David Avran; Hélène Cavé; Nicole Dastugue; Susana Raimondi; Jules P P Meijerink; Carlos Cordon-Cardo; Andrea Califano; Adolfo A Ferrando
Journal:  Nat Med       Date:  2010-10-24       Impact factor: 53.440

8.  Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.

Authors:  Giusy Della Gatta; Teresa Palomero; Arianne Perez-Garcia; Alberto Ambesi-Impiombato; Mukesh Bansal; Zachary W Carpenter; Kim De Keersmaecker; Xavier Sole; Luyao Xu; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Jules P Meijerink; Andrea Califano; Adolfo A Ferrando
Journal:  Nat Med       Date:  2012-02-26       Impact factor: 53.440
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.